CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Other languages Charles River Laboratories International, Inc. Xetra

Equities

RV6

US1598641074

Delayed Xetra Other stock markets 16:35:34 10/08/2022 BST			5-day change	1st Jan Change
215.8 ^EUR	-2.40%		-.--%	-.--%

06-13	Baird Adjusts Price Target on Charles River Laboratories International to $271 From $270	MT
06-07	The job report just threw a spanner in the works

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : Lyft, Amazon, Fedex, Xpo, Vail Resorts, Unilever...	06-07
Charles River Laboratories Opens New Contract Vivarium Space in Massachusetts	06-06
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : American Airlines, Salesforce, Five Below, Tesla, Okta...	06-06
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville	06-06
Charles River Laboratories, Sanofi Collaborating to Develop Non-Animal Virtual Control Groups for Preclinical Trials	06-04
Charles River Laboratories International, Inc. Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development	05-30
Declaration of Voting Results of Charles River Laboratories International Inc	05-10
Charles River Laboratories International Q1 Non-GAAP Earnings Rise, Revenue Fall; Maintains Full Year 2024 Earnings Guidance	05-09
Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	05-09
Stocks Down Pre-Bell Ahead of Latest Earnings Results; Asia, Europe Churn	05-09
Charles River Laboratories International, Inc. Revises Financial Guidance for 2024	05-09
China trade heats up, UK rates in view	05-09
FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids	04-25
Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission	04-24
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing	04-16
Charles River Laboratories International, Inc. and Deciphex Limited Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology	04-11
Charles River Laboratories, Axovia Therapeutics Collaborate on Developing Rare Disease Gene Therapies	04-09
Charles River Laboratories International, Inc. Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics	04-09
Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus	04-04
Charles River Laboratories International, Inc. and Ship of Theseus Announces Good Manufacturing Practice Plasmid DNA Contract Development and Manufacturing Organization Agreement	04-04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Charles River Laboratories International, Inc. Xetra

Equities

RV6

US1598641074

Other languages

Filters